Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platform

The multiplexed cancer cell line screening platform PRISM demonstrated its utility in testing hundreds of cell lines in a single run, possessing the potential to speed up anti-cancer drug discovery, validation and optimization. Here we described the development and implementation of a next-generatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yifeng, Ji, Xiaodong, Jang, In Sock, Surka, Christine, Hsu, Christy, Wang, Kai, Rolfe, Mark, Bence, Neil, Lu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253734/
https://www.ncbi.nlm.nih.gov/pubmed/34215850
http://dx.doi.org/10.1038/s42003-021-02352-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253734/
https://www.ncbi.nlm.nih.gov/pubmed/34215850
http://dx.doi.org/10.1038/s42003-021-02352-2

Ejemplares similares